How much funding has Peptone raised?

Peptone has raised $42.5M in total funding, most recently a Series A round.

Who are Peptone's investors?

Peptone's investors include Hoxton Ventures, F-Prime Capital, Bessemer VP, dRx Capital, Walden Catalyst, Founders Factory.

Where is Peptone headquartered?

Peptone is headquartered in London, United Kingdom.

What industry is Peptone in?

Peptone operates in Artificial Intelligence, Biotech, Drug Discovery.

Peptone

The Intrinsically Disordered Proteins Company.

London, United Kingdom · Founded 2019 · $42.5M raised

Artificial Intelligence

Biotech

Drug Discovery

Headquarters: London
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: peptone.io
Total Funding: $42.5M
Last Round: $40.0M Series AJun 2022
Rounds: 2

About

Peptone is a biotechnology therapeutics company that uses AI and an experimental physics product engine to design first-in-class small molecules targeting intrinsically disordered proteins (IDPs) — the 6,200 human proteins that AlphaFold 3 cannot model. The company's bespoke hydrogen-deuterium exchange mass spectrometry technology reveals binding pockets invisible to conventional structural biology, while its GPU-based supercomputing engine enables small molecule design in weeks rather than years. Peptone's pipeline is focused on oncology indications where IDPs play a central role. Backed by F-Prime Capital, Bessemer Venture Partners, Hoxton Ventures, Novartis, and Walden Catalyst, Peptone operates labs in London and Switzerland.

Summary

Peptone is an Artificial Intelligence company based in London, United Kingdom, founded in 2019. It has raised $42.5M in total across 2 rounds, most recently a $40.0M Series A round in Jun 2022. Investors include Hoxton Ventures, F-Prime Capital and Bessemer VP.

LinkedIn X (Twitter)